期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

埃博拉病毒疫苗和药物的研发进展及启示 被引量：3

Research on Ebola Vaccines and Drugs:Advances and Reflections
下载PDF
导出
摘要 2014年空前的西非埃博拉疫情,使得埃博拉病毒受到了全世界的广泛关注。针对埃博拉病毒病,目前还没有获批上市的疫苗和药物,但有几种疫苗和药物已在非人灵长类动物中证实了保护效果,其中少数品种已进入临床试验阶段。本文集中介绍几种最具前景的疫苗和药物,并对其发展前景进行了分析和预测。 In West Afi＇ica in 2014, an unprecedented Ebola outbreak drew the attention from all over the world. For the prophylaxis and treatment of Ebola virus disease, there are no approved vaccines and drugs available till now. Fortunately, there are several kinds of vaccines and drugs has confirmed the protection effect in nonhuman primates. Among these, a few varieties have entered clinical trials. This article will focus on several of the most promising vaccines and drugs, and anlayze the prospect of relative research and development.
作者 叶玲玲 仇炜祎 田德桥 李晓倩 郑涛
机构地区 军事医学科学院生物工程研究所
出处 《生物技术通讯》 CAS 2015年第1期5-9,共5页 Letters in Biotechnology
关键词 埃博拉病毒 疫苗 药物 Ebola virus vaccine drug
分类号 R18 [医药卫生—流行病学] R392.1 [医药卫生—免疫学]
  • 相关文献

参考文献25

  • 1Geisbert T W,Pushko P,Anderson K,et al.Evaluation innonhuman primates of vaccines against Ebola virus[J].Emerg Infect Dis,2002,8(5):503-507.
  • 2Sullivan N J,Sanchez A,Rollin P E,et al.Development ofa preventive vaccine for Ebola virus infection in primates[J].Nature,2000,408(6812):605-609.
  • 3Stanley D A,Honko A N,Asiedu C,et al.Chimpanzee ade-novirus vaccine generates acute and durable protective immu-nity against ebolavirus challenge[J/OL].Nat Med,2014,7(pub-lished online).
  • 4Ledgerwood J E,DeZure A D,Stanley D A,et al.Chimpan-zee adenovirus vector ebola vaccine-preliminary report[J/OL].New Eng J Med,2014-12-26(published online).
  • 5Qiu X,Fernando L,Alimonti J B,et al.Mucosal immuniza-tion of cynomolgus macaques with the VSVDeltaG/ZEBOVGPvaccine stimulates strong ebola GP-specific immune responses[J].PLoS One,2009,4(5):e5547.
  • 6NIH-News & Events.NIH begins early human clinical trialof VSV Ebola vaccine[EB/OL].[2014-10-22].http://www.nih.gov/news/health/oct2014/niaid-22.htm.
  • 7Choi J H,Jonsson-Schmunk K,Qiu X,et al.A single doserespiratory recombinant adenovirus-based vaccine provideslong-term protection for non-human primates from lethal Ebo-la infection[J].Mol Pharm,2014,141101110031000,DOI:10.1021/mp500646d.
  • 8Hensley S.Johnson & Johnson Pushes Ahead With EbolaVaccine[EB/OL].[2014-09-04].http://www.npr.org/blogs/health/2014/09/04/345771638/johnson-johnson-pushes-ahead-with-eb-ola-vaccine.
  • 9张桂根,郎建社,王洪亮,刘康泰,蒋澄宇.埃博拉病毒包膜蛋白GP基因DNA疫苗诱导小鼠产生高滴度中和抗体[J].基础医学与临床,2011,31(6):667-671. 被引量：3
  • 10何丽芳,武雯俊,王丽丽,陈敏,王馨,杨宁,黄镇.埃博拉病毒包膜蛋白DNA表达质粒对小鼠中和抗体的诱导作用[J].中国生物制品学杂志,2013,26(6):866-868. 被引量：4

二级参考文献25

  • 1温志远,葛金英,王永,胡森,郝永清,步志高.水泡性口炎病毒印第安纳株反基因操作系统的建立[J].中国预防兽医学报,2006,28(5):489-494. 被引量：10
  • 2Andrea M, Reiko Y, Hiroko M, et al. Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever [J]. PLoS One, 2012, 7(4): e36192.
  • 3Feldmann H, Geisbert T. Ebola haemorrhagic fever [J]. Lancet, 2011, 377(9768): 849-862.
  • 4Nancy J, Thomas W, Joan B, et al. Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs [J]. PLoS Med, 2006, 3(6): e177.
  • 5Hideki E, Barry R, Andrea M, et al. Host response dynamics following lethal infection of rhesus macaques with Zaire ebolavirus [J]. J Infect Dis, 2011, 20(3): S991-998.
  • 6Jones M, Feldmann H, Stroher U, et al. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses [J]. Nat Med, 2005, 11(7): 786-790.
  • 7Feldmann H, Jones M, Daddario K, et al. Effective post-exposure treatment of Ebola [J]. PLoS Pathogens, 2007, 3(1): e2.
  • 8Ogino M, Ebihara H, Lee B, et al. Use of vesicular stomatitis virus pseudotypes bearing hantaan or seoul virus envelope proteins in a rapid and safe neutralization test [J]. Clin Diagn Lab Immunol, 2003, 10(1): 154-60.
  • 9Sanchez A, Yang Zhi-yong, Xu Ling, et al. Biochemical analysis of the secreted and virion glycoproteins of Ebola virus [J]. J Virol, 1998, 72(8): 6442-6447.
  • 10William D, Elizabeth T. Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of ebola virus GP DNA vaccines [J]. J Virol, 2007, 81(4): 1821-1837.

共引文献6

同被引文献17

引证文献3

二级引证文献10

生物技术通讯
2015年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部